Fast Five Quiz: Stress-Related Conditions

George D. Harris, MD, MS


September 26, 2019

The AASM guidelines state that psychological and behavioral interventions are effective and recommended for chronic insomnia, both primary and secondary types. Initial approaches to treatment should include at least one behavioral intervention, such as stimulus control therapy; relaxation therapy; or a combination of cognitive therapy, stimulus control therapy, and sleep restriction therapy with or without relaxation therapy. The AASM guidelines also state that over-the-counter antihistamines, antihistamine/analgesic drugs, barbiturates, barbiturate-type drugs, and chloral hydrate are not recommended for the treatment of chronic insomnia.

According to the AASM guidelines, polysomnography and daytime MSLT are not indicated in the routine assessment of chronic insomnia, including insomnia due to neuropsychiatric or psychiatric disorders. Polysomnography is indicated when sleep apnea or movement disorders are suspected, as well as when initial diagnosis is unclear, treatment fails, or precipitous arousals occur with violent or injurious behavior.

Read more about insomnia.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.